These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1577021)

  • 1. Pseudo infarction ECG pattern occurring during intravenous treatment with flecainide acetate.
    van Aubel KJ; Ruiter JH; Arnold AE; Burgersdijk C
    Eur Heart J; 1992 Jan; 13(1):137-9. PubMed ID: 1577021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1:1 atrioventricular conduction in atrial flutter with digoxin and flecainide.
    Ahsan A; Aldridge R; Bowes R
    Int J Cardiol; 1993 Apr; 39(1):88-90. PubMed ID: 8407013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. His-Purkinje system reentry as a proarrhythmic effect of flecainide.
    Chalvidan T; Cellarier G; Deharo JC; Colin R; Savon N; Barra N; Peyre JP; Djiane P
    Pacing Clin Electrophysiol; 2000 Apr; 23(4 Pt 1):530-3. PubMed ID: 10793448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atrial flutter with 1:1 AV conduction during intravenous flecainide treatment].
    Heldal M; Orning OM
    Tidsskr Nor Laegeforen; 1989 Aug; 109(23):2309-10. PubMed ID: 2505404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal intractable atrial flutter successfully treated with intravenous flecainide.
    Suzumura H; Nitta A; Ono M; Arisaka O
    Pediatr Cardiol; 2004; 25(2):154-6. PubMed ID: 14681740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic effect of flecainide toxicity.
    Courand PY; Sibellas F; Ranc S; Mullier A; Kirkorian G; Bonnefoy E
    Cardiol J; 2013; 20(2):203-5. PubMed ID: 23558880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
    Wolpert C; Echternach C; Veltmann C; Antzelevitch C; Thomas GP; Spehl S; Streitner F; Kuschyk J; Schimpf R; Haase KK; Borggrefe M
    Heart Rhythm; 2005 Mar; 2(3):254-60. PubMed ID: 15851314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugada electrocardiographic pattern elicited by inadvertent flecainide overdose.
    Hudson CJ; Whitner TE; Rinaldi MJ; Littmann L
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1311-3. PubMed ID: 15461724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of atrial paralysis during the use of intravenous flecainide acetate].
    Tognarini S; Pardini E
    Cardiologia; 1989 Aug; 34(8):725-9. PubMed ID: 2514041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of auricular fibrillation and tachycardia using intravenous flecainide].
    Cohen-Solal A; Juliard JM; Jaeger P; Farinotti P; Dahan M; Charlier P; Boujon B; Aumont MC
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1290-6. PubMed ID: 3120666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
    Frandsen F; Pless P; Mickley H; Møller M
    Acta Cardiol; 1990; 45(5):351-7. PubMed ID: 1704167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal pharmacokinetics of flecainide in a "nonresponder".
    van Gelder IC; Crijns HJ; van Wijk LM; van Gilst WH; Lie KI
    Clin Cardiol; 1988 May; 11(5):353-5. PubMed ID: 3133149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide induced atrial tachycardia with 1:1 ventricular conduction during exercise testing.
    Randazzo DN; Schweitzer P; Stein E; Banas JS; Winters SL
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1509-14. PubMed ID: 7991422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of acute ventricular capture threshold rise associated with flecainide acetate.
    Kang TS; Yoon YW; Park S; Hong BK; Kim D; Kwon HM; Kim HS
    Yonsei Med J; 2006 Feb; 47(1):152-4. PubMed ID: 16502500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infusion of flecainide in a patient with atrial fibrillation and latent Brugada's syndrome has determined modifications of the electrocardiogram similar to those of a septal myocardial infarct].
    Vitiello N; Cirillo R; Fontana D; Granato L; Sestri C; Pagano V; D'Errico L; Carotenuto F; di Palma F
    Ital Heart J Suppl; 2003 Feb; 4(2):128-32. PubMed ID: 12762263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm.
    Kondili A; Kastrati A; Popa Y
    Wien Klin Wochenschr; 1990 Sep; 102(17):510-3. PubMed ID: 2124756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute flecainide toxicity.
    Yang XS; Sun JP; Zhi GN
    Chin Med J (Engl); 1990 Jul; 103(7):606-7. PubMed ID: 2119980
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L; Alvarez A; Cianciulli T; Quiroga J; Califano J; Mautner B
    Arch Inst Cardiol Mex; 1989; 59(3):241-4. PubMed ID: 2506843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.